Stem cell researchers: Better cytomegalovirus drugs are needed

09/22/2013 | Healio

Drug resistance was seen in almost 15% of hematopoietic stem cell transplant patients who received pre-emptive cytomegalovirus therapy in a study at Hadassah Hebrew University Medical Center in Israel. The study shows the need for cytomegalovirus drugs that act on different targets and can be better tolerated by patients, researchers wrote in The Journal of Infectious Diseases.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA